Company Quick10K Filing
New Residential Investment
10-K 2020-12-31 Filed 2021-02-16
10-Q 2020-09-30 Filed 2020-10-29
10-Q 2020-06-30 Filed 2020-07-27
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-10-29
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-02
10-K 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-07-30
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-15
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-02-22
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-06-12
8-K 2020-10-26
8-K 2020-09-18
8-K 2020-09-15
8-K 2020-07-22
8-K 2020-06-18
8-K 2020-05-19
8-K 2020-05-05
8-K 2020-04-03
8-K 2020-03-31
8-K 2020-02-11
8-K 2020-02-06
8-K 2019-10-31
8-K 2019-10-25
8-K 2019-10-15
8-K 2019-10-02
8-K 2019-09-20
8-K 2019-09-09
8-K 2019-08-30
8-K 2019-08-20
8-K 2019-08-15
8-K 2019-08-15
8-K 2019-08-08
8-K 2019-08-01
8-K 2019-07-30
8-K 2019-07-25
8-K 2019-07-02
8-K 2019-06-25
8-K 2019-06-17
8-K 2019-05-31
8-K 2019-05-23
8-K 2019-05-01
8-K 2019-04-12
8-K 2019-03-11
8-K 2019-02-19
8-K 2019-02-12
8-K 2018-11-05
8-K 2018-10-25
8-K 2018-09-07
8-K 2018-08-17
8-K 2018-07-30
8-K 2018-07-26
8-K 2018-07-03
8-K 2018-06-21
8-K 2018-05-24
8-K 2018-04-27
8-K 2018-03-22
8-K 2018-02-13
8-K 2018-01-18
8-K 2018-01-16
8-K 2018-01-16

New Residential Investment Financials

NRZ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash210172305140311188213459432348250259234389291237717432446413355486415509565901
Accounts Receivable9872,0311,5381,5091,5501,5311,6881,8582,6781,7861,0311,0841,0773,4253,9257,0505,3084,488
Inventory
PP&E
Assets2,7422,9325,9596,9997,0397,7738,0947,46814,39515,35615,19317,57217,90517,70418,36520,03023,00021,40522,21422,01222,94430,09131,69133,41036,79241,348
Accounts Payable149
Long-Term Debt4,1095,3785,1055,5866,0625,33910,31111,03911,30612,86312,94412,78313,20913,85916,06915,09915,76114,68615,48521,66322,67325,40828,78330,525
Liabilities1,4971,6714,4465,4385,2285,9186,2445,65311,30012,33012,20614,49314,79214,28714,89715,72818,38116,72617,41716,25017,14524,25425,60326,49729,99234,086
Stockholders' Equity1,2461,2611,2661,2761,4981,5751,5961,5682,8632,8072,7962,7852,8113,1283,2604,1024,4254,5724,6905,6645,7095,7435,9986,8226,7187,178
Income Statement ($MM)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A1342671292120121279101216201920219999119134
Tax0218-7014-6-160821216833347034-6746-22-5
Net Income109638057182152514279629911694131242137337240300614186195915611245
Cash Flow ($MM)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating87482254187-19536-155-4116917418137-37935-274-282514-317-273-300-2,483467
Cash Investing-123-692-1,400320-4981,119-700-537-196222-128-18-259-1,014-1,7621,206-208216-272-4,969-2,753-724-1,774
Cash Financing-17441,267-175333-855137608139-383-70-91921,3342,049-1,217504-7635315,3733,1473,2631,643